PBMS ADVOCATE ON BEHALF OF CONSUMERS TO REDUCE PRESCRIPTION DRUG COSTS
June 19, 2019
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement on the Senate...
Filter by:
Choose a Topic
Filter by Year:Clear Filters- Highlights
- Biosimilars
- Drug Abuse Prevention
- Drug Cost Management
- Drug Coupons & Assistance Programs
- Drug Coverage Mandates
- Drug Price Negotiations & Rebates
- Formulary Design
- Fraud
- Fraud, Waste, & Abuse
- Generic Drug Utilization
- Home Delivery of Drugs
- Mark Merritt
- Medicaid
- Medicare Part D
- Patient Cost Sharing
- Pharmacy Networks
- Pharmacy Reimbursement & Contracting
- Specialty Pharmacies
- TRICARE
- Waste
PBM Expertise Crucial to Success of Potential New Rebate System in Medicare and Medicaid
May 30, 2019
PBMs are an important link in the drug supply and payment chain that includes manufacturers, wholesalers, physicians, pharmacies and Pharmacy...
Pharmacy Benefit Managers Support Increased Transparency in Prescription Drug Supply Chain
May 20, 2019
(Washington, D.C.) — As the Energy and Commerce Subcommittee on Health examines ways to bring more transparency to prescription drug...
PBMs Set the Record Straight on Value to Consumers
May 06, 2019
Appearing recently before the Senate Finance Committee, executives for pharmacy benefit managers had the opportunity to set the record straight...
New Medicare Prescription Drug Rebate Rule: Wrong Solution to High Drug Prices
March 06, 2019
Prescription drug list prices in the United States continue to be a source of frustration for patients and policymakers alike....
PCMA Unveils New Campaign on the Value of Pharmacy Benefit Managers
February 04, 2019
As the debate on high-cost prescription drugs continues and policymakers seek solutions to reduce out-of-control prices for consumers, the Pharmaceutical Care...
Drug Manufacturer Price Hikes Offset by Rebates
December 20, 2018
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on reports that...
November 14, 2018
The drug giants moved in near-perfect synchronicity, raising prices for their top-selling arthritis treatments as though they were opposite-corner gas...
Morning Consult: Will the Trump Drug-Pricing Initiative Wreck the Medicare Part D Success Story?
November 09, 2018
First, rebates are directly responsible for lowering Part D premiums and program spending....
MarketWatch: Pfizer will go back to price hikes ‘as normal’ come January, CEO suggests
October 31, 2018
Pfizer Inc. will likely go back to “business as normal” for drug price increases...
The Cleveland Plain Dealer: Corral Ohio’s Medicaid ‘Pac-Man’
October 09, 2018
Ohio Medicaid takes better advantage of the expansive industry relationships and pharmacy networks that PBMs have built to provide patients...
Pittsburgh Post-Gazette: We must make prescription drugs affordable
October 09, 2018
PBMs are projected to save $654 billion dollars on drug costs on behalf of 266 million Americans...